查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1498764

治療診斷市場，按治療領域、技術、最終用戶、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Theranostics Market, By Therapeutic Area, By Technology, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 325 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2023 年治療診斷市場規模為 23.902 億美元，2024 年至 2032 年複合年成長率為 13.90%。

治療診斷市場-市場動態

對精準醫療的日益關注推動了治療診斷市場

精準醫學方法在腫瘤學、神經病學、心臟病學和傳染病學等各個醫學領域獲得了廣泛關注。資料顯示，2022年全球精準醫療治療總支出約320億美元。到 2027 年，預計總支出將增至 1,240 億美元左右。隨著基因組學、蛋白質組學和其他組學技術的進步，醫療保健提供者可以更好地了解疾病的分子機制，並識別有助於預測治療反應的生物標記。例如，治療診斷學是一種先進的肺癌精準醫學模型，它將個別或目標族群疾病的預防、診斷和治療結合起來，以適應個別患者的特徵。除了臨床特徵外，它還需要收集和整合肺癌患者的基因組、轉錄組、蛋白質組和代謝組特性。

治療診斷市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032）每年將以 13.90% 左右的複合年成長率成長

根據治療領域細分，預計腫瘤學將在 2023 年顯示最大的市場佔有率

根據最終用戶細分，醫院和診所是 2023 年的主導類型

按地區分類，北美是 2023 年的主要收入來源

治療診斷學市場細分分析：

全球治療診斷市場根據治療領域、技術、最終用戶和地區進行細分。

根據最終用戶，市場分為三類：醫院和診所、診斷實驗室和其他。透過識別與疾病相關的特定分子標靶，治療診斷學可以促進標靶治療的實施。這種方法提高了治療精確度和有效性，並減少了對健康組織的附帶損害。許多治療診斷技術可以無縫整合到現有的醫療保健基礎設施中，使患者和臨床醫生可以輕鬆使用它們，而無需大量額外的資源或基礎設施。

根據治療領域，市場分為五類：神經系統疾病、免疫系統疾病、心血管疾病、腫瘤和其他疾病。肺癌、子宮頸癌、大腸直腸癌、乳癌和其他癌症在腫瘤科下進一步細分。該市場由腫瘤學領域引領，預計在預測期內將繼續領先。這是因為治療診斷學在癌症治療中的應用越來越廣泛，以減少治療延遲、消除過程中的許多步驟並加強患者護理。

治療診斷市場-地理洞察

由於完善的醫療保健系統、強大的研究機構和有利的監管框架，北美地區在治療診斷的進步方面往往處於領先地位。尤其是美國，在治療診斷的開發和應用方面擁有幾個關鍵參與者。北美擁有許多積極參與治療診斷研究和開發的領先製藥公司。這些公司擁有資源和專業知識來加速治療診斷產品的商業化並將其推向市場。由於醫療基礎設施投資增加、慢性病盛行率上升以及對精準醫療的日益重視，中國、印度和韓國等新興經濟體的治療診斷正在快速成長。

治療診斷市場-競爭格局：

專門從事診斷影像技術的公司也在治療診斷市場上競爭。他們開發用於疾病診斷和監測的成像劑和技術。例子包括 GE Healthcare、Siemens Healthineers 和 Philips Healthcare。放射性製藥公司專注於治療診斷中使用的放射性藥物的開發和生產。這些公司在為癌症等各種疾病提供標靶治療方面發揮著至關重要的作用。製藥公司、診斷公司和研究機構等不同利害關係人之間的合作在治療診斷市場中很常見。這些合作關係透過利用互補的專業知識和資源，促進治療診斷產品的開發和商業化。例如，生物梅里埃與葛蘭素史克簽署了一項協議，開發一種預測測試，幫助臨床醫生為不同部位的乳癌患者選擇最合適的治療方法。

最近的發展：

2023 年 6 月，ICPO 基金會和 FMRI 最近透露了一項參考中心合作，將提高放射分子精準腫瘤學 (RPO) 的全球教育標準，並協助在印度建立新型治療診斷中心。

目錄

第1章：治療診斷市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按治療領域分類的治療診斷市場片段
    • 按技術分類的治療診斷市場片段
    • 最終使用者的治療診斷市場片段
    • 按國家/地區分類的治療診斷市場摘要
    • 按地區分類的治療診斷市場片段
  • 競爭洞察

第 3 章：治療診斷主要市場趨勢

  • 治療診斷市場促進因素
    • 市場促進因素的影響分析
  • 治療診斷市場限制
    • 市場限制影響分析
  • 治療診斷市場機會
  • 治療診斷市場未來趨勢

第 4 章：治療診斷產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：治療診斷市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：治療診斷市場格局

  • 2023 年治療診斷市佔率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：治療診斷市場 - 按治療領域

  • 概述
    • 按治療領域分類的細分市場佔有率分析
    • 腫瘤學
      • 乳癌
      • 肺癌
      • 大腸直腸癌
      • 子宮頸癌
      • 其他
    • 心血管疾病
    • 免疫系統疾病
    • 神經系統疾病
    • 其他

第 8 章：治療診斷市場 - 按技術分類

  • 概述
    • 按技術分類的細分市場佔有率分析
    • 聚合酶鍊式反應 (PCR)
    • 免疫組織化學 (IHC)
    • 定序
    • 原位雜合技術 (ISH)
    • 其他

第 9 章：治療診斷市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 醫院和診所
    • 診斷實驗室
    • 其他

第 10 章：治療診斷市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美治療診斷主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模與預測（按治療領域）
    • 北美市場規模和預測（按技術）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲治療診斷主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模與預測（按治療領域）
    • 歐洲市場規模與預測（按技術）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區治療診斷主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（按治療領域）
    • 亞太地區市場規模與預測（按技術）
    • 亞太地區市場規模和預測（按最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲治療診斷主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按治療領域）
    • 拉丁美洲市場規模與預測（按技術）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲治療診斷主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按治療領域）
    • 中東和非洲市場規模及預測（按技術）
    • 中東和非洲市場規模和預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析 - 治療診斷產業

  • 競爭儀表板
  • 公司簡介
    • Thermo Fisher Scientific Inc.
    • AmeriPath, Inc.
    • Beckman Coulter, Inc.
    • Foundation Medicine, Inc.
    • Hoffmann-La Roche Ltd
    • Myriad Genetics, Inc.
    • Focus Diagnostics
    • Abbott Laboratories
    • Illumina, Inc.
    • QIAGEN
    • Agilent Technologies, Inc.
    • Others

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV2935

REPORT HIGHLIGHT

Theranostics Market size was valued at USD 2,390.20 million in 2023, expanding at a CAGR of 13.90% from 2024 to 2032.

The theranostics market involves the combination of diagnostics with therapeutics to create personalized treatment plans for patients. This approach allows for tailored therapy based on an individual's specific genetic makeup, disease state, and other relevant factors. The key drivers of the theranostics market are the growing focus on personalized medicine and precision healthcare. By using diagnostic tests to identify biomarkers or specific molecular targets, healthcare providers can better match patients with the most effective treatments, potentially improving outcomes and reducing adverse effects. Furthermore, the increasing prevalence of chronic diseases, such as cancer and cardiovascular disorders, has fueled the demand for innovative therapeutic approaches.

Theranostics Market- Market Dynamics

Increasing focus on precision medicines propelling the theranostics market

Precision medicine approaches have gained traction across various medical fields, including oncology, neurology, cardiology, and infectious diseases. As per data, in 2022, total spending on treatments with precision medicine stood at some 32 billion U.S. dollars globally. By 2027, it is projected that total spending will increase to around 124 billion dollars. With advancements in genomics, proteomics, and other omics technologies, healthcare providers can better understand the molecular mechanisms underlying diseases and identify biomarkers that help predict treatment response. Forr instance, Theranostics, an advanced model of precision medicine for lung cancer, combines prevention, diagnosis, and treatment for individual or targeted population disorders to accommodate individual patient characteristics. In addition to clinical traits, it entails gathering and integrating lung cancer patient's genome, transcriptome, proteome, and metabolome properties.

Theranostics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 13.90% over the forecast period (2024-2032)

Based on Therapeutic Area segmentation, oncology was predicted to show maximum market share in the year 2023

Based on end-user segmentation, Hospitals, and Clinics was the leading type in 2023

based on region, North America was the leading revenue generator in 2023

Theranostics Market- Segmentation Analysis:

The Global Theranostics Market is segmented on the basis of Therupatic Area, Technology, End User, and Region.

The market is divided into three categories based on end-users: Hospitals and Clinics, Diagnostic Laboratories, and Others. By identifying specific molecular targets associated with diseases, theranostics facilitates targeted therapy delivery. This approach enhances treatment precision, and effectiveness, and reduces collateral damage to healthy tissues. Many theranostic techniques can be seamlessly integrated into existing healthcare infrastructure, making them readily accessible to patients and clinicians without requiring significant additional resources or infrastructure.

The market is divided into five categories based on therapeutic area: Neurological conditions, immunological disorders, cardiovascular illnesses, oncology, and other conditions. Lung cancer, cervical cancer, colorectal cancer, breast cancer, and other cancers are further subdivided under the oncology section. The market was led by the oncology segment, which is anticipated to continue leading during the projection period. This is because theranostics is becoming more widely used in cancer therapy to reduce treatment delays, eliminate many steps in the process, and enhance patient care.

Theranostics Market- Geographical Insights

North America region often leads in theranostics advancements due to well-established healthcare systems, strong research institutions, and favorable regulatory frameworks. The United States, in particular, hosts several key players in theranostics development and adoption. North America is home to many leading pharmaceutical companies that are actively involved in theranostics research and development. These companies have the resources and expertise to accelerate the commercialization of theranostic products and bring them to market. Emerging economies like China, India, and South Korea are witnessing rapid growth in theranostics due to increasing investments in healthcare infrastructure, rising prevalence of chronic diseases, and a growing emphasis on precision medicine.

Theranostics Market- Competitive Landscape:

Companies specializing in diagnostic imaging technologies also compete in the theranostics market. They develop imaging agents and technologies used for the diagnosis and monitoring of diseases. Examples include GE Healthcare, Siemens Healthineers, and Philips Healthcare. Radiopharmaceutical companies focus on the development and production of radiopharmaceuticals used in theranostics. These companies play a crucial role in providing targeted therapies for various diseases such as cancer. Collaboration between different stakeholders such as pharmaceutical companies, diagnostic companies, and research institutions is common in the theranostics market. These partnerships facilitate the development and commercialization of theranostic products by leveraging complementary expertise and resources. For instance, bioMerieux has signed an agreement with GlaxoSmithKline to develop a predictive test to help clinicians select the most appropriate treatment for different segments of breast cancer patients.

Recent Developments:

In June 2023, The ICPO Foundation and FMRI recently revealed a reference center cooperation that will foster global standards of education in Radiomolecular Precision Oncology (RPO) and assist in setting up novel Theranostics Centres in India.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL THERANOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Thermo Fisher Scientific Inc.

AmeriPath, Inc.

Beckman Coulter, Inc.

Foundation Medicine, Inc.

Hoffmann-La Roche Ltd

Myriad Genetics, Inc.

Focus Diagnostics

Abbott Laboratories

Illumina, Inc.

QIAGEN

Agilent Technologies, Inc.

Others

GLOBAL THERANOSTICS MARKET, BY THERUPATIC AREA - MARKET ANALYSIS, 2019 - 2032

  • Oncology
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Cervical Cancer
  • Others
  • Cardiovascular Diseases
  • Immunological Disorders
  • Neurological Disorders
  • Others

GLOBAL THERANOSTICS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Polymerase Chain Reaction (PCR)
  • Immunohistochemistry (IHC)
  • Sequencing
  • In Situ Hybridization (ISH)
  • Others

GLOBAL THERANOSTICS MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Others

GLOBAL THERANOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Theranostics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Theranostics Market Snippet by Therupatic Area
    • 2.1.2. Theranostics Market Snippet by Technology
    • 2.1.3. Theranostics Market Snippet by End User
    • 2.1.4. Theranostics Market Snippet by Country
    • 2.1.5. Theranostics Market Snippet by Region
  • 2.2. Competitive Insights

3. Theranostics Key Market Trends

  • 3.1. Theranostics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Theranostics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Theranostics Market Opportunities
  • 3.4. Theranostics Market Future Trends

4. Theranostics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Theranostics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Theranostics Market Landscape

  • 6.1. Theranostics Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Theranostics Market - By Therupatic Area

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Therupatic Area, 2023 & 2032 (%)
    • 7.1.2. Oncology
      • 7.1.2.1. Breast Cancer
      • 7.1.2.2. Lung Cancer
      • 7.1.2.3. Colorectal Cancer
      • 7.1.2.4. Cervical Cancer
      • 7.1.2.5. Others
    • 7.1.3. Cardiovascular Diseases
    • 7.1.4. Immunological Disorders
    • 7.1.5. Neurological Disorders
    • 7.1.6. Others

8. Theranostics Market - By Technology

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology, 2023 & 2032 (%)
    • 8.1.2. Polymerase Chain Reaction (PCR)
    • 8.1.3. Immunohistochemistry (IHC)
    • 8.1.4. Sequencing
    • 8.1.5. In Situ Hybridization (ISH)
    • 8.1.6. Others

9. Theranostics Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 9.1.2. Hospitals and Clinics
    • 9.1.3. Diagnostic Laboratories
    • 9.1.4. Others

10. Theranostics Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Theranostics Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Theranostics Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Theranostics Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Theranostics Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Theranostics Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Therupatic Area, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Theranostics Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Thermo Fisher Scientific Inc.
    • 11.2.2. AmeriPath, Inc.
    • 11.2.3. Beckman Coulter, Inc.
    • 11.2.4. Foundation Medicine, Inc.
    • 11.2.5. Hoffmann-La Roche Ltd
    • 11.2.6. Myriad Genetics, Inc.
    • 11.2.7. Focus Diagnostics
    • 11.2.8. Abbott Laboratories
    • 11.2.9. Illumina, Inc.
    • 11.2.10. QIAGEN
    • 11.2.11. Agilent Technologies, Inc.
    • 11.2.12. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Theranostics Market: Therupatic Area Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Therupatic Area
  • TABLE Global Theranostics Market, by Therupatic Area 2019-2032 (USD Million)
  • TABLE Theranostics Market: Technology Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Technology
  • TABLE Global Theranostics Market, by Technology 2019-2032 (USD Million)
  • TABLE Theranostics Market: End User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Theranostics Market, by End User 2019-2032 (USD Million)
  • TABLE Theranostics Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Theranostics Market, by Region 2019-2032 (USD Million)
  • TABLE North America Theranostics Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Theranostics Market, by Therupatic Area, 2019-2032 (USD Million)
  • TABLE North America Theranostics Market, by Technology, 2019-2032 (USD Million)
  • TABLE North America Theranostics Market, by End User, 2019-2032 (USD Million)
  • TABLE Europe Theranostics Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Theranostics Market, by Therupatic Area, 2019-2032 (USD Million)
  • TABLE Europe Theranostics Market, by Technology, 2019-2032 (USD Million)
  • TABLE Europe Theranostics Market, by End User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Theranostics Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Theranostics Market, by Therupatic Area, 2019-2032 (USD Million)
  • TABLE Asia Pacific Theranostics Market, by Technology, 2019-2032 (USD Million)
  • TABLE Asia Pacific Theranostics Market, by End User, 2019-2032 (USD Million)
  • TABLE Latin America Theranostics Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Theranostics Market, by Therupatic Area, 2019-2032 (USD Million)
  • TABLE Latin America Theranostics Market, by Technology, 2019-2032 (USD Million)
  • TABLE Latin America Theranostics Market, by End User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Theranostics Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Theranostics Market, by Therupatic Area, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Theranostics Market, by Technology, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Theranostics Market, by End User, 2019-2032 (USD Million)